2021 | Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis | NEW ENGLAND JOURNAL OF MEDICINE |
2021 | Association between body image dissatisfaction and poor quality of life and depression among patients with hematopoietic stem cell transplantation | SUPPORTIVE CARE IN CANCER |
2021 | Clinical characteristics and prognostic factors of acquired haemophilia A in Korea | HAEMOPHILIA |
2021 | Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma
| BONE MARROW TRANSPLANTATION |
2021 | Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma | CLINICAL CANCER RESEARCH |
2021 | Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): an open-label phase I/II trial
| ANNALS OF ONCOLOGY |
2021 | Safety, pharmacokinetics, and pharmacodynamics of a next-generation subcutaneously administered coagulation factor IX variant, dalcinonacog alfa, in previously treated hemophilia B patients | JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
2021 | Updated recommendations for the treatment of venous thromboembolism
| BLOOD RESEARCH |
2021 | Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients
| JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION |
2021 | Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells
| EXPERIMENTAL HEMATOLOGY & ONCOLOGY |
2021 | Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2021 | Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study
| JOURNAL OF HEMATOLOGY & ONCOLOGY |
2021 | Impact of depression on adherence to lenalidomide plus low-dose dexamethasone in patients with relapsed or refractory myeloma | SUPPORTIVE CARE IN CANCER |
2021 | Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone | INTERNATIONAL JOURNAL OF HEMATOLOGY |
2021 | Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas | ANNALS OF HEMATOLOGY |
2021 | Treatment outcome and prognostic factors of Korean patients with chronic lymphocytic leukemia: a multicenter retrospective study
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2020 | Human herpesvirus 8-negative effusion-based lymphoma with indolent clinical behavior in an elderly patient: A case report and literature review
| ONCOLOGY LETTERS |
2020 | Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX
| BLOOD CANCER JOURNAL |
2020 | Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis | LEUKEMIA & LYMPHOMA |
2020 | Distinct genetic profile with recurrent population-specific missense variants in Korean adult atypical hemolytic uremic syndrome | THROMBOSIS RESEARCH |
2020 | Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database
| CANCER RESEARCH AND TREATMENT |
2020 | Immunosuppressive role of CD11b + CD33 + HLA-DR - myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemia
| CANCER MEDICINE |
2020 | Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphoma | ANNALS OF HEMATOLOGY |
2020 | First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial
| CANCERS |
2020 | Association between sexuality knowledge and sexual dysfunction in hematopoietic stem cell transplantation patients and their partners | PATIENT EDUCATION AND COUNSELING |
2020 | Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL) | BONE MARROW TRANSPLANTATION |
2020 | Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era
| SCIENTIFIC REPORTS |
2020 | Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study | INTERNATIONAL JOURNAL OF HEMATOLOGY |
2020 | Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host disease | ANNALS OF HEMATOLOGY |
2020 | ULK1 Inhibition as a Targeted Therapeutic Strategy for FLT3-ITD-mutated Acute Myeloid Leukemia
| JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
2020 | Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)
| AMERICAN JOURNAL OF HEMATOLOGY |
2020 | Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial
| CANCER RESEARCH AND TREATMENT |
2020 | PERK/NRF2 and Autophagy Form a Resistance Mechanism Against G9a Inhibition in Leukemia Stem Cells
| JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
2020 | The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria | BLOOD |
2020 | The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study) | ANNALS OF HEMATOLOGY |
2020 | A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma | ANNALS OF HEMATOLOGY |
2020 | Analysis of the Efficacy of Thalidomide Plus Dexamethasone-Based Regimens in Patients With Relapsed/Refractory Multiple Myeloma Who Received Prior Chemotherapy, Including Bortezomib and Lenalidomide: KMM-166 Study | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA |
2020 | Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2019 | Clinical Implication of Renal Dysfunction During the Clinical Course in Patients With Paroxysmal Nocturnal Hemoglobinuria: A Longitudinal Analysis | ANNALS OF HEMATOLOGY |
2019 | 후천성 혈우병 A
| Clinical and Experimental Thrombosis and Hemostasis |
2019 | 국소적 대상포진이 발생한 면역저하환자로부터 유발된 수두의 발생
| Korean Journal of Nosocomial Infection Control (병원감염관리) |
2019 | Early Cytomegalovirus Reactivation and Expansion of CD56brightCD16dim/-DNAM1+ Natural Killer Cells Are Associated with Antileukemia Effect after Haploidentical Stem Cell Transplantation in Acute Leukemia | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
2019 | Induction of apoptosis and differentiation by Na/H exchanger 1 modulation in acute myeloid leukemia cells | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
2019 | A Phase I/II, Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of Lower Doses of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: The KMM103 Study | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
2019 | Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimization | Japanese Journal of Clinical Oncology |
2018 | Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial | LANCET HAEMATOLOGY |
2018 | Screening audit' as a quality assurance tool in good clinical practice compliant research environments
| BMC MEDICAL ETHICS |
2018 | Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150) | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
2018 | HBsAg-Negative, Anti-HBc-Negative Patients Still Have a Risk of Hepatitis B Virus-Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma
| CANCER RESEARCH AND TREATMENT |
2018 | A prognostic scoring system for patients with multiple myeloma classified as stage II with the Revised International Staging System | BRITISH JOURNAL OF HAEMATOLOGY |